Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy
Abstract Background Clostridium novyi-NT (CNV-NT), has shown promise as a bacterolytic therapy for solid tumors in mouse models and in dogs with naturally developing neoplasia. Factors that impact the immunologic response to therapy are largely unknown. The goal of this pilot study was to determine...
Main Authors: | Amy E. DeClue, Sandra M. Axiak-Bechtel, Yan Zhang, Saurabh Saha, Linping Zhang, David D. Tung, Jeffrey N. Bryan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-018-1424-1 |
Similar Items
-
Immune response to C. novyi-NT immunotherapy
by: Amy E. DeClue, et al.
Published: (2018-04-01) -
Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy
by: Ann-Marie Malby Schoos, et al.
Published: (2020-11-01) -
Dogs with osteosarcoma have altered pro‐ and anti‐inflammatory cytokine profiles
by: Sandra M. Axiak‐Bechtel, et al.
Published: (2019-11-01) -
Immunological Changes on Allergic Response after Beevenom Immunotherapy
by: Dong-Ha Han
Published: (2004-12-01) -
Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
by: Jia-yan Xin, et al.
Published: (2021-09-01)